The orthobiologics devices and equipment market size has grown strongly in recent years. It will grow from $5.99 billion in 2025 to $6.36 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increase in musculoskeletal disorders, sports injury prevalence, orthopedic surgery growth, adoption of PRP therapies, clinical success of bone grafts.
The orthobiologics devices and equipment market size is expected to see strong growth in the next few years. It will grow to $8.64 billion in 2030 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to aging population growth, regenerative medicine innovation, minimally invasive treatment demand, reimbursement expansion, technological advancements in biomaterials. Major trends in the forecast period include rising adoption of regenerative therapies, growth in sports injury treatments, increasing use of stem cell-based products, preference for non-surgical orthopedic treatments, expansion of orthopedic clinics.
The increasing prevalence of orthopedic disorders is increasingly supporting the expansion of the orthobiologics devices and equipment market going forward. Orthopedic disorders affect the musculoskeletal system, including bones, joints, muscles, ligaments, tendons, and nerves. Demand for orthopedic treatments continues to rise due to aging populations, as older individuals are more susceptible to conditions such as osteoarthritis, osteoporosis, and fractures. Orthobiologics devices and equipment support natural tissue regeneration, enhance bone and joint repair, and improve functional recovery. These solutions contribute to improved treatment outcomes by accelerating healing and reducing recovery time. For example, in August 2023, according to the Institute for Health Metrics and Evaluation, a US-based public health research institute, approximately 15% of individuals aged 30 and older were affected by osteoarthritis in 2023, with the global affected population projected to approach 1 billion by 2050. Consequently, the rising prevalence of orthopedic disorders is reinforcing growth across the orthobiologics devices and equipment market.
Leading companies operating in the orthobiologics devices and equipment market are focusing on advanced regenerative technologies, such as synthetic bone fusion gels, to improve surgical outcomes, accelerate healing, and reduce complications. Synthetic bone fusion gels are biomaterial formulations that function as scaffolds and delivery systems for growth factors, promoting bone regeneration in orthopedic and spinal fusion procedures. For example, in January 2024, Renovos Biologics Ltd., a UK-based biomaterials company, received FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, Renovite BMP-2. This injectable, moldable gel is designed to localize bone morphogenetic protein-2 at the surgical site, promoting controlled bone healing while reducing the risk of ectopic bone formation and soft-tissue complications.
In January 2023, Zimmer Biomet Holdings Inc., a US-based medical technology company, acquired Embody Inc. for an undisclosed amount. This acquisition is intended to reinforce Zimmer Biomet’s expanding sports medicine portfolio by integrating Embody’s advanced soft-tissue healing solutions and supporting the company’s long-term transformation strategy. Embody Inc. is a US-based medical device company offering collagen-based soft-tissue regeneration implants for orthobiologic applications.
Major companies operating in the orthobiologics devices and equipment market are BONESUPPORT AB, Medtronic plc, Kuros Biosciences Ltd., Stryker Corporation, Baxter International Inc., DePuy Synthes, Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., Enovis Corp., Integra Lifesciences Holding Corporation, NuVasive Inc., Globus Medical Inc., Bioventus LLC, Orthofix Medical Inc., SeaSpine Holdings Corporation, Xtant Medical Holdings Inc., Acumed LLC, Bone Biologics Corp.
North America was the largest region in the global Ortho biologics devices and equipment market in 2025. Western Europe was the second-largest region in the orthobiologics devices and equipment market report. The regions covered in the orthobiologics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the orthobiologics devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the orthobiologics market by raising costs of imported biomaterials, processing equipment, and raw biological inputs. Synthetic bone substitutes and stem cell therapy products are most affected, especially in North America and Europe. Increased costs may limit adoption in cost-sensitive healthcare settings. Positively, tariffs are promoting domestic manufacturing, local sourcing of biomaterials, and innovation in synthetic alternatives.
The orthobiologics devices and equipment market research report is one of a series of new reports that provides orthobiologics devices and equipment market statistics, including orthobiologics devices and equipment industry global market size, regional shares, competitors with a orthobiologics devices and equipment market share, detailed orthobiologics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the orthobiologics devices and equipment industry. This orthobiologics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Orthobiologic devices are implants made from natural cells and proteins that help accelerate healing by stimulating the regeneration of bones, cartilage, tendons, and ligaments.
The primary product categories of orthobiologics devices and equipment include demineralized bone matrix, synthetic bone substitutes, stem cell therapy, platelet-rich plasma, viscosupplementation, bone morphogenetic proteins, and synthetic orthobiologics. Stem cell therapy involves stimulating the repair and regeneration of damaged, diseased, or dysfunctional tissues using stem cells or their derivatives. The applications include osteoarthritis and degenerative arthritis, soft tissue injuries, fracture healing, maxillofacial and dental treatments, spinal fusion, trauma repair, and reconstructive surgery, and these products are used by end users such as hospitals, orthopedic clinics, and others.
The orthobiologics devices and equipment market consists of sales of demineralized bone matrix, synthetic bone substitutes, stem cell therapy, plasma-rich protein, viscosupplementation, bone morphogenetic protein, and other synthetic orthobiologics. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The orthobiologics devices and equipment market size is expected to see strong growth in the next few years. It will grow to $8.64 billion in 2030 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to aging population growth, regenerative medicine innovation, minimally invasive treatment demand, reimbursement expansion, technological advancements in biomaterials. Major trends in the forecast period include rising adoption of regenerative therapies, growth in sports injury treatments, increasing use of stem cell-based products, preference for non-surgical orthopedic treatments, expansion of orthopedic clinics.
The increasing prevalence of orthopedic disorders is increasingly supporting the expansion of the orthobiologics devices and equipment market going forward. Orthopedic disorders affect the musculoskeletal system, including bones, joints, muscles, ligaments, tendons, and nerves. Demand for orthopedic treatments continues to rise due to aging populations, as older individuals are more susceptible to conditions such as osteoarthritis, osteoporosis, and fractures. Orthobiologics devices and equipment support natural tissue regeneration, enhance bone and joint repair, and improve functional recovery. These solutions contribute to improved treatment outcomes by accelerating healing and reducing recovery time. For example, in August 2023, according to the Institute for Health Metrics and Evaluation, a US-based public health research institute, approximately 15% of individuals aged 30 and older were affected by osteoarthritis in 2023, with the global affected population projected to approach 1 billion by 2050. Consequently, the rising prevalence of orthopedic disorders is reinforcing growth across the orthobiologics devices and equipment market.
Leading companies operating in the orthobiologics devices and equipment market are focusing on advanced regenerative technologies, such as synthetic bone fusion gels, to improve surgical outcomes, accelerate healing, and reduce complications. Synthetic bone fusion gels are biomaterial formulations that function as scaffolds and delivery systems for growth factors, promoting bone regeneration in orthopedic and spinal fusion procedures. For example, in January 2024, Renovos Biologics Ltd., a UK-based biomaterials company, received FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, Renovite BMP-2. This injectable, moldable gel is designed to localize bone morphogenetic protein-2 at the surgical site, promoting controlled bone healing while reducing the risk of ectopic bone formation and soft-tissue complications.
In January 2023, Zimmer Biomet Holdings Inc., a US-based medical technology company, acquired Embody Inc. for an undisclosed amount. This acquisition is intended to reinforce Zimmer Biomet’s expanding sports medicine portfolio by integrating Embody’s advanced soft-tissue healing solutions and supporting the company’s long-term transformation strategy. Embody Inc. is a US-based medical device company offering collagen-based soft-tissue regeneration implants for orthobiologic applications.
Major companies operating in the orthobiologics devices and equipment market are BONESUPPORT AB, Medtronic plc, Kuros Biosciences Ltd., Stryker Corporation, Baxter International Inc., DePuy Synthes, Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., Enovis Corp., Integra Lifesciences Holding Corporation, NuVasive Inc., Globus Medical Inc., Bioventus LLC, Orthofix Medical Inc., SeaSpine Holdings Corporation, Xtant Medical Holdings Inc., Acumed LLC, Bone Biologics Corp.
North America was the largest region in the global Ortho biologics devices and equipment market in 2025. Western Europe was the second-largest region in the orthobiologics devices and equipment market report. The regions covered in the orthobiologics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the orthobiologics devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the orthobiologics market by raising costs of imported biomaterials, processing equipment, and raw biological inputs. Synthetic bone substitutes and stem cell therapy products are most affected, especially in North America and Europe. Increased costs may limit adoption in cost-sensitive healthcare settings. Positively, tariffs are promoting domestic manufacturing, local sourcing of biomaterials, and innovation in synthetic alternatives.
The orthobiologics devices and equipment market research report is one of a series of new reports that provides orthobiologics devices and equipment market statistics, including orthobiologics devices and equipment industry global market size, regional shares, competitors with a orthobiologics devices and equipment market share, detailed orthobiologics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the orthobiologics devices and equipment industry. This orthobiologics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Orthobiologic devices are implants made from natural cells and proteins that help accelerate healing by stimulating the regeneration of bones, cartilage, tendons, and ligaments.
The primary product categories of orthobiologics devices and equipment include demineralized bone matrix, synthetic bone substitutes, stem cell therapy, platelet-rich plasma, viscosupplementation, bone morphogenetic proteins, and synthetic orthobiologics. Stem cell therapy involves stimulating the repair and regeneration of damaged, diseased, or dysfunctional tissues using stem cells or their derivatives. The applications include osteoarthritis and degenerative arthritis, soft tissue injuries, fracture healing, maxillofacial and dental treatments, spinal fusion, trauma repair, and reconstructive surgery, and these products are used by end users such as hospitals, orthopedic clinics, and others.
The orthobiologics devices and equipment market consists of sales of demineralized bone matrix, synthetic bone substitutes, stem cell therapy, plasma-rich protein, viscosupplementation, bone morphogenetic protein, and other synthetic orthobiologics. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Orthobiologics Devices and Equipment Market Characteristics
3. Orthobiologics Devices and Equipment Market Supply Chain Analysis
4. Global Orthobiologics Devices and Equipment Market Trends and Strategies
5. Orthobiologics Devices and Equipment Market Analysis of End Use Industries
7. Global Orthobiologics Devices and Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Orthobiologics Devices and Equipment Total Addressable Market (TAM) Analysis for the Market
9. Orthobiologics Devices and Equipment Market Segmentation
10. Orthobiologics Devices and Equipment Market Regional and Country Analysis
11. Asia-Pacific Orthobiologics Devices and Equipment Market
12. China Orthobiologics Devices and Equipment Market
13. India Orthobiologics Devices and Equipment Market
14. Japan Orthobiologics Devices and Equipment Market
15. Australia Orthobiologics Devices and Equipment Market
16. Indonesia Orthobiologics Devices and Equipment Market
17. South Korea Orthobiologics Devices and Equipment Market
18. Taiwan Orthobiologics Devices and Equipment Market
19. South East Asia Orthobiologics Devices and Equipment Market
20. Western Europe Orthobiologics Devices and Equipment Market
21. UK Orthobiologics Devices and Equipment Market
22. Germany Orthobiologics Devices and Equipment Market
23. France Orthobiologics Devices and Equipment Market
24. Italy Orthobiologics Devices and Equipment Market
25. Spain Orthobiologics Devices and Equipment Market
26. Eastern Europe Orthobiologics Devices and Equipment Market
27. Russia Orthobiologics Devices and Equipment Market
28. North America Orthobiologics Devices and Equipment Market
29. USA Orthobiologics Devices and Equipment Market
30. Canada Orthobiologics Devices and Equipment Market
31. South America Orthobiologics Devices and Equipment Market
32. Brazil Orthobiologics Devices and Equipment Market
33. Middle East Orthobiologics Devices and Equipment Market
34. Africa Orthobiologics Devices and Equipment Market
36. Orthobiologics Devices and Equipment Market Competitive Landscape and Company Profiles
37. Orthobiologics Devices and Equipment Market Other Major and Innovative Companies
40. Orthobiologics Devices and Equipment Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Orthobiologics Devices And Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses orthobiologics devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for orthobiologics devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The orthobiologics devices and equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Demineralized Bone Matrix; Synthetic Bone Substitutes; Stem Cell Therapy; Plasma-Rich Protein; Viscosupplementation; Bone Morphogenetic Protein; Synthetic Orthobiologics2) By Application: Osteoarthritis And Degenerative Arthritis; Soft-Tissue Injuries; Fracture Recovery; Maxillofacial And Dental Applications; Spinal Fusion; Trauma Repair; Reconstructive Surgery
3) By End Use: Hospitals; Orthopedic Clinics; Other End Users
Subsegments:
1) By Demineralized Bone Matrix: Injectable Demineralized Bone Matrix; Paste And Putty Forms; Demineralized Bone Matrix Scaffolds2) By Synthetic Bone Substitutes: Calcium Phosphate Ceramics; Bioactive Glasses; Polymers And Composites
3) By Stem Cell Therapy: Adipose-Derived Stem Cell Products; Bone Marrow-Derived Stem Cell Products; Umbilical Cord Blood-Derived Stem Cell Products
4) By Plasma-Rich Protein: Platelet-Rich Plasma (PRP) Products; Platelet-Rich Fibrin (PRF) Products
5) By Viscosupplementation: Hyaluronic Acid Injections; Combination Viscosupplementation Products
6) By Bone Morphogenetic Protein (BMP): Recombinant Bone Morphogenetic Proteins; BMP Delivery Systems
7) By Synthetic Orthobiologics: Growth Factor-Enhanced Products; Biodegradable Scaffolds With Bioactive Agents; Other Synthetic Formulations
Companies Mentioned: BONESUPPORT AB; Medtronic plc; Kuros Biosciences Ltd.; Stryker Corporation; Baxter International Inc.; DePuy Synthes; Braun Melsungen AG; Zimmer Biomet Holdings Inc.; Smith & Nephew plc; Arthrex Inc.; Enovis Corp.; Integra Lifesciences Holding Corporation; NuVasive Inc.; Globus Medical Inc.; Bioventus LLC; Orthofix Medical Inc.; SeaSpine Holdings Corporation; Xtant Medical Holdings Inc.; Acumed LLC; Bone Biologics Corp.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Orthobiologics Devices and Equipment market report include:- BONESUPPORT AB
- Medtronic plc
- Kuros Biosciences Ltd.
- Stryker Corporation
- Baxter International Inc.
- DePuy Synthes
- Braun Melsungen AG
- Zimmer Biomet Holdings Inc.
- Smith & Nephew plc
- Arthrex Inc.
- Enovis Corp.
- Integra Lifesciences Holding Corporation
- NuVasive Inc.
- Globus Medical Inc.
- Bioventus LLC
- Orthofix Medical Inc.
- SeaSpine Holdings Corporation
- Xtant Medical Holdings Inc.
- Acumed LLC
- Bone Biologics Corp.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 6.36 Billion |
| Forecasted Market Value ( USD | $ 8.64 Billion |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
